Company intelligence / Profile preview

Tekia

Irvine, California, United Statestekia.com ↗

Ownership: Private
Employees: ~200
Development stage: Commercial

Overview

Tekia has received European approval to market its accommodating intraocular lens for presbyopia and distributes the Kelman Duet Refractive IOL in the EU and South America. The company was preparing to submit an IDE application to the FDA as of early/mid-2000s.

Therapeutic areas: Ophthalmology
Modalities: DeviceIntraocular lens implant
Industry: Implantable Medical Devices

Partnerships

Co-development with Dr. Charles D. Kelman on Kelman Duet IOL

Beyond the preview

Go deeper on Tekia.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tekia.

Explore the full profile